Clinical Trial Update: To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablets Under Fasting Conditions [Phase 1]

View source ↗

Summary

A Phase 1 study was conducted to demonstrate the relative bioequivalence of lisinopril 40 mg tablets under fasting conditions. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Lisinopril (Lisinopril)

Snippet

Sponsor: Sandoz | Conditions: Hypertension | Phase 1 | Status: COMPLETED